Report Code : CVMI2412248 | Published Date : March 3, 2025
The global Alopecia Treatment Market was valued at 8.3 billion in 2023 and is projected to reach 18.6 billion by 2031, growing at a CAGR of 10.4%. The market is driven by the rising prevalence of hair loss disorders, advancements in regenerative medicine, and increasing demand for minimally invasive solutions.
2024 Market Breakthroughs
- JAK Inhibitor Approvals:
- Olumiant® (baricitinib) sales surge 75% YoY for severe alopecia areata.
- Litfulo® (ritlecitinib) is the first FDA-approved treatment for adolescents.
- Stem Cell Therapies:
- RepliCel’s RCH-01 shows 85% hair regrowth in Phase II trials.
- HairClone’s Hair Bank launches in the UK for follicular cell preservation.
- Robotic Hair Restoration:
- ARTAS iX® robot achieves 40% faster graft placement vs. manual FUE.
Market Drivers
1. Rising Prevalence
- 147 million people affected globally (NIH, 2024).
- 40% of men experience noticeable hair loss by age 35.
2. Treatment Innovations
- Topical Foams:
- Minoxidil 10% formulations improve compliance by 30%.
- Low-Level Laser Therapy (LLLT):
- Capillus® FDA-cleared devices grow at 22% CAGR.
3. Aesthetic Demand
- Medical Tourism: Turkey’s hair transplant market hits USD 1.2 billion.
- Celebrity Endorsements: Public figures reduce stigma (e.g., Jada Pinkett Smith).
Competitive Landscape
Company |
Market Share |
Flagship Product |
Strategic Edge |
Eli Lilly |
28% |
Olumiant® (JAK inhibitor) |
First systemic AA treatment |
Pfizer |
XX% |
Litfulo® (JAK3/TEC) |
Pediatric indication |
Restoration Robotics |
XX% |
ARTAS iX® |
AI-powered FUE |
Emerging Disruptors:
- Stemson Therapeutics: iPSC-derived hair follicles (Series B: USD50M).
- Follica: Micro-needling + topical cocktails (Phase III).
Market Segmentation
- By Type:
- Androgenetic Alopecia (XX%): Dominates market.
- Alopecia Areata (XX%): Fastest-growing segment.
- By Treatment:
- Pharmacological (50%): JAKs, minoxidil.
- Surgical (XX%): FUE, FUT.
- Devices (XX%): LLLT, PRP.
- By Region:
- North America (XX%): High biologic adoption.
- Europe (30%): Medical tourism hub.
- Asia-Pacific (XX%): Rising disposable income.
Recent Developments (2024)
- May 2024: Olumiant® approved in Japan for pediatric AA.
August 2024: Stemson’s iPSC hair follicles enter clinical trials
Reasons To Buy

Scope

Key Players
- Alopecia Treatment Market – Johnson & Johnson
- Merck & Co. Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Cipla Ltd.
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy’s Laboratories
- Cellmid Limited
- Follicum AB
- Concert Pharmaceuticals Inc.
Global Alopecia Treatment Market Report
Global Alopecia Treatment Market Report
- 1. Global Alopecia Treatment Market Research Report
- 1.1 Study Objectives
- 1.2 Global Alopecia Treatment Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Alopecia Treatment Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Treatment Type
- 2.1.2 By End-user
- 2.1.3 By Application
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Treatment Type, By End-user, By Application, By Country
- 3.3. Opportunities – By Treatment Type, By End-user, By Application, By Country
- 3.4. Trends – By Treatment Type, By End-user, By Application, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Alopecia Treatment Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Topical Treatment
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Oral Treatment
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Injectable Treatment
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.4 Hair Transplantation
- 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Hospitals
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Clinics
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Homecare Settings
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Male Alopecia
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Female Alopecia.
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Europe
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Asia-Pacific
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4 Latin America
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5 Middle East & Africa
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.6 Global Alopecia Treatment Market - Opportunity Analysis Index, By Treatment Type, By End-user, By Application, and Region, 2024 - 2031
- 9.1 By Treatment Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Topical Treatment
- 9.1.2 Oral Treatment
- 9.1.3 Injectable Treatment
- 9.1.4 Hair Transplantation
- 9.2.1 Hospitals
- 9.2.2 Clinics
- 9.2.3 Homecare Settings
- 9.3.1 Male Alopecia
- 9.3.2 Female Alopecia.
- 9.4.1 United States
- 9.4.2 Canada
9.6 Regional Trends Analysis
9.7 North America Global Alopecia Treatment Market Research Report - Company Profiles- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Treatment Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Topical Treatment
- 10.1.2 Oral Treatment
- 10.1.3 Injectable Treatment
- 10.1.4 Hair Transplantation
- 10.2.1 Hospitals
- 10.2.2 Clinics
- 10.2.3 Homecare Settings
- 10.3.1 Male Alopecia
- 10.3.2 Female Alopecia.
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands
- 10.4.8 Poland
- 10.4.9 Rest of Europe
10.6 Regional Trends Analysis
10.7 Europe Global Alopecia Treatment Market Research Report - Company Profiles- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Treatment Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Topical Treatment
- 11.1.2 Oral Treatment
- 11.1.3 Injectable Treatment
- 11.1.4 Hair Transplantation
- 11.2.1 Hospitals
- 11.2.2 Clinics
- 11.2.3 Homecare Settings
- 11.3.1 Male Alopecia
- 11.3.2 Female Alopecia.
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & NZ
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Alopecia Treatment Market Research Report - Company Profiles- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Treatment Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Topical Treatment
- 12.1.2 Oral Treatment
- 12.1.3 Injectable Treatment
- 12.1.4 Hair Transplantation
- 12.2.1 Hospitals
- 12.2.2 Clinics
- 12.2.3 Homecare Settings
- 12.3.1 Male Alopecia
- 12.3.2 Female Alopecia.
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
12.6 Regional Trends Analysis
12.7 Latin America Global Alopecia Treatment Market Research Report - Company Profiles- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Treatment Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Topical Treatment
- 13.1.2 Oral Treatment
- 13.1.3 Injectable Treatment
- 13.1.4 Hair Transplantation
- 13.2.1 Hospitals
- 13.2.2 Clinics
- 13.2.3 Homecare Settings
- 13.3.1 Male Alopecia
- 13.3.2 Female Alopecia.
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Alopecia Treatment Market Research Report - Company Profiles- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 14.2.1 Alopecia Treatment Market – Johnson & Johnson
- 14.2.2 Merck & Co. Inc.
- 14.2.3 Pfizer Inc.
- 14.2.4 GlaxoSmithKline plc
- 14.2.5 Cipla Ltd.
- 14.2.6 Sun Pharmaceutical Industries Ltd.
- 14.2.7 Dr. Reddy’s Laboratories
- 14.2.8 Cellmid Limited
- 14.2.9 Follicum AB
- 14.2.10 Concert Pharmaceuticals Inc.
16. Principal Presumptions and Acronym